Trinity Biotech (TRIB)

• Market cap: $7.83M
• 1 day: -9.02%
• 5 days: 46.1%
• 1 month: -0.51%
• 3 months: -35.56%
• 6 months: -52.79%
• Year to date: -48.19%
• 1 year: -43.63%
• 5 years: -96.42%
• 10 years: -99.4%
• Sector: Healthcare
• Industry: Medical Devices

About: Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.

Employees: 287